[{"address1": "645 Summer Street", "address2": "Suite 101", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 273 8343", "website": "https://ikenaoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. As of July 25, 2025, Ikena Oncology, Inc. was acquired by Inmagene Biopharmaceuticals Co. Ltd.", "fullTimeEmployees": 9, "companyOfficers": [], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1751328000, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 1.37, "open": 1.38, "dayLow": 1.36, "dayHigh": 1.4796, "regularMarketPreviousClose": 1.37, "regularMarketOpen": 1.38, "regularMarketDayLow": 1.36, "regularMarketDayHigh": 1.4796, "payoutRatio": 0.0, "beta": 0.501, "forwardPE": -20.188234, "volume": 457262, "regularMarketVolume": 457262, "averageVolume": 18002, "averageVolume10days": 67534, "averageDailyVolume10Day": 67534, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 718823808, "fiftyTwoWeekLow": 1.36, "fiftyTwoWeekHigh": 23.28, "fiftyDayAverage": 15.75, "twoHundredDayAverage": 17.0754, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -20955902, "profitMargins": 0.0, "floatShares": 6112372, "sharesOutstanding": 41889500, "sharesShort": 14052, "sharesShortPriorMonth": 6722, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.08003, "heldPercentInstitutions": 0.76208, "shortRatio": 0.88, "shortPercentOfFloat": 0.0004, "impliedSharesOutstanding": 48258100, "bookValue": 28.822, "priceToBook": 0.5953785, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -30744000, "trailingEps": -7.68, "forwardEps": -0.85, "lastSplitFactor": "1:12", "lastSplitDate": 1753660800, "enterpriseToEbitda": 0.508, "52WeekChange": -0.12269938, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 17.16, "targetHighPrice": 276.00012, "targetLowPrice": 276.00012, "targetMeanPrice": 276.00012, "targetMedianPrice": 276.00012, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 95642000, "totalCashPerShare": 1.982, "ebitda": -41217000, "totalDebt": 5677000, "quickRatio": 13.059, "currentRatio": 13.519, "debtToEquity": 4.898, "returnOnAssets": -0.18319, "returnOnEquity": -0.23762, "grossProfits": -29890000, "freeCashflow": -22731250, "operatingCashflow": -29182000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IKNA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Ikena Oncology, Inc.", "longName": "Ikena Oncology, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616765400000, "regularMarketChange": 15.79, "fiftyTwoWeekHighChange": -6.120001, "fiftyTwoWeekHighChangePercent": -0.2628866, "fiftyTwoWeekChangePercent": -12.2699375, "earningsTimestamp": 1746707400, "earningsTimestampStart": 1754569800, "earningsTimestampEnd": 1754569800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -7.68, "epsForward": -0.85, "epsCurrentYear": -4.92, "priceEpsCurrentYear": -3.487805, "regularMarketDayRange": "1.36 - 1.4796", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 18002, "fiftyTwoWeekLowChange": 15.8, "fiftyTwoWeekLowChangePercent": 11.617647, "fiftyTwoWeekRange": "1.36 - 23.28", "fiftyDayAverageChange": 1.4099998, "fiftyDayAverageChangePercent": 0.0895238, "twoHundredDayAverageChange": 0.08460045, "twoHundredDayAverageChangePercent": 0.0049545225, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-26", "averageAnalystRating": "2.0 - Buy", "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1753473600, "exchange": "NGM", "messageBoardId": "finmb_302325481", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1152.55, "regularMarketPrice": 17.16, "cryptoTradeable": false, "displayName": "Ikena Oncology", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]